News
AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE
AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.
News & Events
Keep up to date on AgNovos events and related news
Featured posts
All Articles
AgNovos Healthcare to Participate in Italian Society of Orthopedics, Medicine and Rare Diseases of the Skeleton Congress
AgNovos Healthcare will participate in this year’s Italian Society of Orthopedics, Medicine and Rare Diseases of the Skeleton (OrtoMed) congress from December 9-11.
2021 ESCEO-AgNovos Young Investigator Award
It is with great pleasure that AgNovos Healthcare announces the recipients of this year’s ESCEO-AgNovos Young Investigator Award presented at the World Congress on Osteoporosis in August 2021.
New Manuscript on Using AGN1 Implant Material to Treat Bone Loss Published in Peer-Reviewed Journal
AgNovos Healthcare is pleased to announce the publication of a manuscript titled “AGN1 implant material to treat bone loss: Resorbable implant forms normal bone with and without alendronate in a canine critical size humeral defect model” in the peer-reviewed journal Bone.
AgNovos Healthcare to Participate in German Congress of Orthopedics and Traumatology
AgNovos Healthcare will participate once again in this year’s German Congress of Orthopedics and Traumatology (DKOU) from October 26-29.
World Osteoporosis Day 2021
World Osteoporosis Day, marked on October 20th each year, is a day dedicated to raising global awareness of the prevention, diagnosis, and treatment of osteoporosis and related metabolic diseases.
AgNovos Healthcare to Participate in German Bones, Muscles, and Joints Conference
AgNovos Healthcare will participate again in this year’s Bones, Muscles, and Joints conference on October 8th and 9th.